XPENG (NYSE:XPEV - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "strong sell" rating to a "sell" rating in a note issued to investors on Saturday, Wall Street Zen reports.
A number of other research analysts also recently weighed in on XPEV. JPMorgan Chase & Co. decreased their target price on shares of XPENG from $11.50 to $10.00 and set a "neutral" rating for the company in a research report on Monday, October 26th. The Goldman Sachs Group set a $16.00 price target on shares of XPENG in a research report on Friday, October 23rd. Weiss Ratings raised shares of XPENG from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Tuesday. Freedom Broker reduced their price objective on shares of XPENG from $22.00 to $20.00 and set a "buy" rating for the company in a research note on Tuesday. Finally, HSBC cut XPENG from a "buy" rating to a "hold" rating and set a $10.10 price objective for the company. in a report on Friday. Five analysts have rated the stock with a Buy rating, four have given a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, XPENG has a consensus rating of "Hold" and an average target price of $16.94.
View Our Latest Report on XPEV
XPENG Trading Down 14.2%
NYSE:XPEV opened at $8.05 on Friday. The company has a market cap of $7.69 billion, a P/E ratio of -14.37 and a beta of 0.96. XPENG has a twelve month low of $8.02 and a twelve month high of $21.99. The business has a 50 day moving average price of $9.70 and a two-hundred day moving average price of $13.80. The company has a quick ratio of 0.86, a current ratio of 1.11 and a debt-to-equity ratio of 0.50.
XPENG (NYSE:XPEV - Get Free Report) last posted its quarterly earnings data on Monday, November 16th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.03). The business had revenue of $3.62 billion during the quarter, compared to analyst estimates of $3.44 billion. XPENG had a negative net margin of 4.57% and a negative return on equity of 12.90%. As a group, analysts expect that XPENG will post -0.65 EPS for the current fiscal year.
Institutional Investors Weigh In On XPENG
Several large investors have recently made changes to their positions in XPEV. Global Retirement Partners LLC increased its stake in shares of XPENG by 1,584.5% during the 3rd quarter. Global Retirement Partners LLC now owns 3,470 shares of the company's stock worth $33,000 after purchasing an additional 3,264 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in shares of XPENG by 57.5% in the 3rd quarter. Farther Finance Advisors LLC now owns 4,850 shares of the company's stock valued at $46,000 after purchasing an additional 1,771 shares during the period. CX Institutional acquired a new stake in XPENG in the 3rd quarter valued at about $60,000. Integrated Wealth Concepts LLC acquired a new stake in XPENG in the 2nd quarter valued at about $81,000. Finally, TD Waterhouse Canada Inc. lifted its stake in XPENG by 91.4% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 6,680 shares of the company's stock valued at $91,000 after purchasing an additional 3,190 shares during the last quarter. Institutional investors and hedge funds own 21.09% of the company's stock.
Key Stories Impacting XPENG
Investors following XPEV have been watching these stories:
- Negative Sentiment: HSBC downgraded XPENG from Buy to Hold, tempering analyst sentiment. Its $10.10 price target nevertheless implies potential upside from the current level. HSBC Downgrades XPeng to Hold
- Negative Sentiment: XPENG’s targeted 45%–50% fourth-quarter delivery growth faces a margin test: a greater mix of lower-priced models may limit profitability, despite overseas sales prospects. XPeng's Q4 Delivery Growth Outlook Faces a Bigger Margin Test
- Negative Sentiment: The company’s latest reported quarter missed the consensus EPS estimate, reinforcing investor concerns about profitability. Shares are also near their 52-week low.
About XPENG
(
Get Free Report)
XPENG Inc. is a Chinese electric vehicle company that designs, develops, manufactures and sells smart electric vehicles. Founded in 2014 and headquartered in Guangzhou, the company focuses on combining vehicle engineering with software and technology features. Its product lineup includes electric sedans, SUVs and multipurpose vehicles. XPENG also develops driver-assistance technologies, in-car software and related services, and operates charging infrastructure to support its vehicles. The company primarily serves customers in China and has expanded into international markets.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider XPENG, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and XPENG wasn't on the list.
While XPENG currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.